---
figid: PMC12119701__13402_2025_1044_Fig8_HTML
figtitle: Possible mechanism underlying KCTD1-enhanced HCC progression
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12119701
filename: 13402_2025_1044_Fig8_HTML.jpg
figlink: /pmc/articles/PMC12119701/figure/F8/
number: F8
caption: Schematic representation of the possible mechanism underlying KCTD1-enhanced
  HCC progression. KCTD1 interacts with HIF-1α/β in the nucleus, binds with the promoter
  of the VEGF gene, and activates VEGF expression, subsequently binding with VEGFR2
  on the HCC cell surface and promoting the VEGF caspase signal pathway. On the one
  hand, miR-129-5p binds with 3′UTR of the KCTD1 gene, suppresses KCTD1 protein level,
  and exosomes delivering miR-129-5p reverse its tumor-promoting role of KCTD1. On
  the other hand, sorafenib and KCTD1 knockdown synergistically inhibit HCC progression.
  HIF-1β designates as ARNT
papertitle: Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular
  carcinoma progression via the KCTD1/HIF-1α/VEGF pathway
reftext: Xinyu Zhu, et al. Cell Oncol (Dordr). 2025 Apr 14;48(3).
year: '2025'
doi: 10.1007/s13402-025-01044-x
journal_title: Cellular Oncology (Dordrecht, Netherlands)
journal_nlm_ta: Cell Oncol (Dordr)
publisher_name: .na.character
keywords: KCTD1 | Hepatocellular carcinoma | HIF-1α | Sorafenib | Exosome
automl_pathway: 0.9460443
figid_alias: PMC12119701__F8
figtype: Figure
redirect_from: /figures/PMC12119701__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12119701__13402_2025_1044_Fig8_HTML.html
  '@type': Dataset
  description: Schematic representation of the possible mechanism underlying KCTD1-enhanced
    HCC progression. KCTD1 interacts with HIF-1α/β in the nucleus, binds with the
    promoter of the VEGF gene, and activates VEGF expression, subsequently binding
    with VEGFR2 on the HCC cell surface and promoting the VEGF caspase signal pathway.
    On the one hand, miR-129-5p binds with 3′UTR of the KCTD1 gene, suppresses KCTD1
    protein level, and exosomes delivering miR-129-5p reverse its tumor-promoting
    role of KCTD1. On the other hand, sorafenib and KCTD1 knockdown synergistically
    inhibit HCC progression. HIF-1β designates as ARNT
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - HIF1A
  - SETD2
  - ARNT
  - KCTD1
  - HCC
  - HYCC1
  - Sorafenib
---
